Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and a Favorable Safety Profile

Click here to view

Presentation

IL23R-CAR-Tregs – A Novel Approach to Treat Crohn’s Disease (CD) Patients

Download PDF